Haemonetics Aktie
WKN: 881782 / ISIN: US4050241003
|
07.08.2026 04:52:06
|
Haemonetics Corp Q1 Sales Increase
(RTTNews) - Haemonetics Corp (HAE) reported a profit for first quarter of $33.01 million
The company's earnings came in at $33.01 million, or $0.72 per share. This compares with $34.03 million, or $0.70 per share, last year.
Excluding items, Haemonetics Corp reported adjusted earnings of $52.29 million or $1.14 per share for the period.
The company's revenue for the period rose 5.6% to $339.38 million from $321.39 million last year.
Haemonetics Corp earnings at a glance (GAAP) :
-Earnings: $33.01 Mln. vs. $34.03 Mln. last year. -EPS: $0.72 vs. $0.70 last year. -Revenue: $339.38 Mln vs. $321.39 Mln last year.
-Guidance: Full year revenue guidance: 5 % To 8 %
FISCAL 2027 GUIDANCE for Adjusted earnings per diluted share is Comparable to reported revenue growth
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Haemonetics Corp.
| Keine Nachrichten verfügbar. |
Analysen zu Haemonetics Corp.
Aktien in diesem Artikel
| Haemonetics Corp. | 75,50 | 7,86% |
|